Submitted:
18 January 2024
Posted:
19 January 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Extraction and characterization of HDPs
2.2. Animal exposure
2.3. Serum biochemical analysis
2.4. Histological examination
2.5. Biological determination of injury-related parameters in liver and intestine
2.6. Gut microbiota analysis
2.7. Hepatic metabolomics analysis
2.8. Statistical analysis
3. Results
3.1. Structural characterization of HDPs
3.2. Changes in serum lipid levels
3.3. Liver damage
3.4. Changes in hepatic and intestinal inflammatory cytokines and intestinal enzyme activities
3.5. Dysbiosis of gut microbiota
3.6. Hepatic metabolomics changes
3.7. Correlations of lipid changes and liver metabolites with gut microbiota in alcohol-exposed mice
3.7.1. Relationship between lipid changes and gut microbiota
3.7.2. Relationship between hepatic metabolites and gut microbiota
4. Discussion
4.1. HDPs reduced alcohol-caused lipid abnormalities
4.2. HDPs alleviated alcohol-exposed intestinal dysbiosis and hepatic fatty acid metabolism disorders
4.3. Comparison of HDPs studies
5. Conclusions

Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Data Availability Statement
Conflicts of Interest
References
- World Health Organization. Global status report on alcohol and health 2018. World Health Organization publications: Geneva, Switzerland, 2018; pp. 38-60.
- Zhao, C.L.; Wu, X.L.; Chen, J.; Qian, G.Q. The therapeutic effect of IL-21 combined with IFN-γ inducing CD4+CXCR5+CD57+T cells differentiation on hepatocellular carcinoma. J Adv Res 2021, 36, 89–99. [CrossRef]
- Liu, Y.G.; Wang J; Li, L.Z.; Hu, W.J.; Qu, Y.D.; Ding, Y.P.; Meng, L.N.; Teng, L.R.; Wang, D. Hepatoprotective Effects of Antrodia cinnamomea: The Modulation of oxidative stress signaling in a mouse model of alcohol-induced acute liver injury. Oxid Med Cell Longev 2017, 7841823. [CrossRef]
- Avila, D.V.; Barker, D.F.; Zhang, J.; McClain, C.J.; Barve, S.; Gobejishvili, L. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis. J Pathol 2016, 240, 96–107. [CrossRef]
- Hartmann, P.; Hochrath, K.; Horvath, A.; Chen, P.; Seebauer, C.T.; Llorente, C., Wang, L.R.; Alnouti, Y.; Fouts, D.E.; Peter Stärkel, P.; et al. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hepatology 2018, 67, 2150–2166. [CrossRef]
- Chen, P.; Stärkel, P.; Turner, J.R.; Ho, S.B.; Schnabl, B. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology 2015, 61, 883–894. [CrossRef]
- Lang, S.; Duan, Y.; Liu, J.; Torralba, M.G.; Kuelbs, C.; Ventura-Cots, M.; Abraldes, J.G.; Bosques-Padilla, F.; Verna, E.C.; Brown, R.S.J.; et al. Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis. Hepatology. 2020, 71, 522–538. [CrossRef]
- Maccioni, L.; Gao, B.; Leclercq, S.; Pirlot, B.; Horsmans, Y.; De Timary, P.; Leclercq, I.; Fouts, D.; Schnabl, B.; Stärkel, P. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans. Gut microbes 2020, 12, 1782157. [CrossRef]
- Li, Y.Y.; Zhong, Y.J.; Cheng, Q.; Wang, Y.Z.; Fan, Y.Y.; Yang, C.F.; Ma, Z.H.; Li, Z.H.; Li, L. miR-378b regulates insulin sensitivity by targeting insulin receptor and p110α in alcohol-induced hepatic steatosis. Front Pharmacol 2020, 11, 717. [CrossRef]
- Ambade, A.; Lowe, P.; Kodys, K.; Catalano, D.; Gyongyosi, B.; Cho, Y.; Vellve, A.I.; Adejumo, A.; Saha, B.; Calenda, C. Pharmacological inhibition of ccr2/5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice. Hepatology 2019, 69, 1105–1121. [CrossRef]
- Pi, A.W.; Jiang, K.; Ding, Q.C.; Lai, S.L.; Yang, W.W.; Zhu, J.Y.; Guo, R.; Fan, Y.B.; Chi, L.F.; Li, S.T. Alcohol abstinence rescues hepatic steatosis and liver injury via improving metabolic reprogramming in chronic alcohol-fed mice. Front Pharmacol 2021, 12, 752148. [CrossRef]
- Caslin, B., Mohler, K., Thiagarajan, S., Melamed, E. Alcohol as friend or foe in autoimmune diseases: a role for gut microbiome?. Gut microbes 2021, 13, 1916278. [CrossRef]
- Yang, B.; Wu, Q.J.; Luo, Y.X.; Yang Q, Wei, X.Y., Kan, J.Q. High-pressure ultrasonic-assisted extraction of polysaccharides from Hovenia dulcis: Extraction, structure, antioxidant activity and hypoglycemic. Int J Biol Macromol 2019, 137, 676–687. [CrossRef]
- Qiu, P.; Dong, Y.; Zhu, T.; Luo, Y.Y.; Kang, X.J.; Pang, M.X.; Li, H.Z.; Xu, H.; Gu, C.; Pan, S.H. Semen hoveniae extract ameliorates alcohol-induced chronic liver damage in rats via modulation of the abnormalities of gut-liver axis. Phytomedicine 2019, 52, 40–50. [CrossRef]
- Sferrazza, G.; Brusotti, G.; Zonfrillo, M.; Temporini, C.; Tengattini, S.; Bononi, M.; Tateo, F.; Calleri, E.; Pierimarchi, P. Hovenia dulcis Thumberg: Phytochemistry, pharmacology, toxicology and regulatory framework for its use in the European Union. Molecules 2021, 26, 903. [CrossRef]
- Meng, X.; Tang, G.Y.; Zhao, C.N.; Liu, Q.; Xu, X.Y.; Cao, S.Y. Hepatoprotective effects of Hovenia dulcis seeds against alcoholic liver injury and related mechanisms investigated via network pharmacology. World J Gastroenterol 2020, 26, 3432–3446. [CrossRef]
- Hyun, T.K.; Eom, S.H.; Yu, C.Y.; Roitsch, T. Hovenia dulcis--an Asian traditional herb. Planta Med 2010, 76, 943-949. [CrossRef]
- Yang, B.; Luo, Y.X.; Sang, Y.X.; Kan, J.Q. Isolation, purification, structural characterization, and hypoglycemic activity assessment of polysaccharides from Hovenia dulcis (Guai Zao). Int J Biol Macromol 2022, 208, 1106–1115. [CrossRef]
- Yang, B.; Luo, Y.X.; Wei, X.Y.; Kan, J.Q. Polysaccharide from Hovenia dulcis (Guaizao) improves pancreatic injury and regulates liver glycometabolism to alleviate STZ-induced type 1 diabetes mellitus in rats. Int J Biol Macromol 2022, 214, 655–663. [CrossRef]
- Tang, H.H.; Zhu, S.L. Research progress of Hovenia dulcis’ antialcoholism and liver protection effect. Food and Nutrition in China 2012, 18, 69–72. (in Chinese with English abstract). [CrossRef]
- Choi, R.Y.; Woo, M.J.; Ham, J.R.; Lee, M.K. Anti-steatotic and anti-inflammatory effects of Hovenia dulcis Thunb extracts in chronic alcohol-fed rats. Biomed Pharmacother 2017, 90, 393–401. [CrossRef]
- Liu, Y.; Qiang, M.L.; Sun, Z.G.; Du, Y.Q. Optimization of ultrasonic extraction of polysaccharides from Hovenia dulcis peduncles and their antioxidant potential. Int J Biol Macromol 2015, 80, 350-357. [CrossRef]
- Liu, X.D.; Zhang, Y.C.; Zhu, S.J.; Song, Y.; Zhang, Z.H.; Chen, G.X. Optimization of extraction process of polysaccharides from Hovenia dulcis fruit pedicels and its antioxidant activity. Science and Technology of Food Industry 2023, 44, 230-237. (in Chinese with English abstract). [CrossRef]
- Li, C. Replication of Animal Models for Human Diseases. People’s Medical Publishing House: Beijing, China, 2008; pp. 60-62.
- Wong, H.L.X.; Qin, H.Y.; Tsang, S.W.; Zuo, X.; Che, S.; Chow, C.F.W.; Li, X.; Xiao, H.T.; Zhao, L.; Huang, T. Early life stress disrupts intestinal homeostasis via NGF-TrkA signaling. Nat Commun 2019, 10, 1745. [CrossRef]
- Chen, X.; Li, H.D.; Bu, F.T.; Li, X.F.; Chen, Y.; Zhu, S.; Wang, J.N.; Chen, S.Y.; Sun, Y.Y.; Pan, X.Y.; et al. Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis. Theranostics 2020, 10, 4851–4870. [CrossRef]
- Zhang, Y.; Jia, X.B.; Liu, Y.C.; Yu, W.Q.; Si, Y.H.; Guo, S.D. Fenofibrate enhances lipid deposition via modulating PPARγ, SREBP-1c, and gut microbiota in ob/ob mice fed a high-fat diet. Front Nutr 2020, 9, 971581. [CrossRef]
- Han, H.; Wang, M.Y.; Zhong, R.Q.; Yi, B.; Schroyen, M.; Zhang, H.F. Depletion of gut microbiota inhibits hepatic lipid accumulation in high-fat diet-fed mice. Int J Mol Sci 2022, 23, 9350-9371. [CrossRef]
- Lu, X.R.; Ma, N.; Liu, X.W.; Li, S.H.; Qin, Z.; Bai, L.X.; Yang, Y.J.; Li, J.Y. Untargeted and targeted metabolomics reveal the underlying mechanism of aspirin eugenol ester ameliorating rat hyperlipidemia via inhibiting fxr to induce cyp7a1. Front Pharmacol 2021,12, 733789. [CrossRef]
- Xia, J.; Wishart, D.S. Using MetaboAnalyst 3.0 for comprehensive metabolomics data analysis. Curr Protoc Bioinformatics 2016, 55, 11–14. [CrossRef]
- Arab, J.P.; Cabrera, D.; Sehrawat, T.S.; Jalan-Sakrikar, N.; Verma, V.K.; Simonetto, D.; Cao, S.; Yaqoob, U.; Leon, J.; Freire, M. Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12. J Hepatol 2020, 73, 149–160. [CrossRef]
- Clugston, R.D.; Huang, L.S.; Blaner, W.S. Chronic alcohol consumption has a biphasic effect on hepatic retinoid loss. FASEB J 2015, 29, 3654–3667. [CrossRef]
- Yang. C.; Liao, A.M.; Cui, Y.; Yu, G.; Hou, Y.; Pan, L.; Chen, W.J.; Zheng, S.N.; Li, X.X.; Ma, J.R.; et al. Wheat embryo globulin protects against acute alcohol-induced liver injury in mice. Food Chem Toxicol 2021, 153, 112240. [CrossRef]
- Zhao, J.; Zhang, S.L.; You, S.P.; Liu, T.; Xu, F.; Ji, T.F.; Gu, Z.Y. Hepatoprotective effects of nicotiflorin from nymphaea candida against concanavalin a-induced and d-galactosamine-induced liver injury in mice. Int J Mol Sci 2017, 18, 587. [CrossRef]
- Gu, C.W.; Zhou, Z.H.; Yu, Z.H.; He, M.L.; He, L.Q.; Luo, Z.A.; Xiao, W.D.; Yang, Q.; Zhao, F.F.; Li, L.H.; et al. The microbiota and it's correlation with metabolites in the gut of mice with nonalcoholic fatty liver disease. Front Cell Infect Microbiol 2022, 12, 870785. [CrossRef]
- Frandsen, H.S.; Vej-Nielsen, J.M.; Smith, L.E.; Sun, L.; Mikkelsen, K.L.; Thulesen, A.P.; Hagensen, C.E.; Yang, F.Q.; Rogowska-Wrzesinska, A. Mapping proteome and lipidome changes in early-onset non-alcoholic fatty liver disease using hepatic 3d spheroids. Cells 2022, 11, 3216. [CrossRef]
- Samuelson, D.R.; Shellito, J.E.; Maffei, V.J.; Tague, E.D.; Campagna, S.R.; Blanchard, E.E.; Luo, M.; Taylor, C.M.; Ronis, M.J.J.; Molina, P.E.; et al. Alcohol-associated intestinal dysbiosis impairs pulmonary host defense against Klebsiella pneumoniae. PLoS Pathog 2017, 13, e1006426. [CrossRef]
- Duan, Y.; Chu, H.K.; Brandl, K.; Jiang, L.; Zeng, S.L.; Meshgin, N.; Papachristoforou, E.; Argemi, J.; Mendes, B.G.; Wang, Y.H.; et al. CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease. Nat Commun 2021, 12, 7172. [CrossRef]
- Deng, L.; Wojciech, L.; Png, C.W.; Koh, E.Y.; Aung, T.T.; Kioh, D.Y.Q.; Chan, E.C.Y.; Malleret, B.; Zhang, Y.L.; Peng, G.N.; et al. Experimental colonization with Blastocystis ST4 is associated with protective immune responses and modulation of gut microbiome in a DSS-induced colitis mouse model. Cell Mol Life Sci 2022, 79, 245. [CrossRef]
- Yi, Z.W.; Liu, X.F.; Liang, L.H.; Wang, G.Q.; Xiong, Z.Q.; Zhang, H.; Song, X.; Ai, L.Z.; Xia, Y.J. Antrodin a from antrodia camphorata modulates the gut microbiome and liver metabolome in mice exposed to acute alcohol intake. Food Funct 2021, 12, 2925–2937. [CrossRef]
- Zhu, S.L.; Wu, Y.Z.; Ye, X.L.; Ma, L.; Qi, J.Y.; Yu, D.; Wei, Y.Q.; Lin, G.G.; Ren, G.P.; Li, D.S. FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy. Mol Cell Biochem 2016, 420, 107-119. [CrossRef]
- Qu, J.L.; Chen, Q.Y.; Wei, T.F.; Dou, N.; Shang, D.; Yuan, D. Systematic characterization of Puerariae Flos metabolites in vivo and assessment of its protective mechanisms against alcoholic liver injury in a rat model. Front Pharmacol 2022, 13, 915535. [CrossRef]
- Bartel, J.; Krumsiek, J.; Schramm, K.; Adamski, J.; Gieger, C.; Herder, C.; Carstensen, M.; Peters, A.; Rathmann, W.; Roden, M.; et al. The human blood metabolome-transcriptome interface. PLoS Genet 2015, 11: e1005274. [CrossRef]
- Zhu, Y.; Wei, Y.L.; Karras, I.; Cai, P.J.; Xiao, Y.H.; Jia, C.L.; Qian, X.L.; Zhu, S.Y.; Zheng, L.J.; Hu, X.; et al. Modulation of the gut microbiota and lipidomic profiles by black chokeberry (Aronia melanocarpa L.) polyphenols via the glycerophospholipid metabolism signaling pathway. Front Nutr 2022, 9, 913729. [CrossRef]
- Du, L.J.; Wang, Q.; Ji, S.; Sun, Y.F.; Huang, W.J.; Zhang, Y.P.; Li S.S.; Yan, S.K.; Jin, H.Z. Metabolomic and microbial remodeling by shanmei capsule improves hyperlipidemia in high fat food-induced mice. Front Cell Infect Microbiol 2022, 12, 729940. [CrossRef]
- Niiya, M.; Shimato, Y.; Ohno, T.; Makino, T. Effects of Hovenia dulcis fruit and peduncle extract on alcohol metabolism. J Ethnopharmacol 2023, 321: 117541. [CrossRef]
- Wang, M.C.; Zhu, P.L.; Jiang, C.X.; Ma, L.P.; Zhang, Z.J.; Zeng, X.X. Preliminary characterization, antioxidant activity in vitro and hepatoprotective effect on acute alcohol-induced liver injury in mice of polysaccharides from the peduncles of Hovenia dulcis. Food Chem Toxicol 2012, 50, 2964-2970. [CrossRef]








Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).